XCP2,FIZZ2,HXCP2,CCRG,RETNL2,RELMb,Foundin In Flammatory Zone 2,Colon and small intestine-specific cysteine-rich protein,Colon carcinoma-related gene protein
The Human Resistin-Like Beta (RETNLB) ELISA Kit is specifically designed for the accurate measurement of resistin-like beta levels in human samples such as serum, plasma, and cell culture supernatants. This kit offers high sensitivity and specificity, ensuring reliable and reproducible results for a variety of research applications.Resistin-like beta is a protein that plays a role in various physiological processes, including inflammatory responses, lipid metabolism, and insulin sensitivity. Imbalances in resistin-like beta levels have been associated with conditions such as obesity, diabetes, and cardiovascular diseases, making it a valuable biomarker for studying these diseases and potential therapeutic interventions.
Overall, the RETNLB ELISA Kit provides researchers with a powerful tool for investigating the role of resistin-like beta in human health and disease, ultimately advancing our understanding of these conditions and facilitating the development of targeted treatment strategies.
Product Name:
Human Resistin Like Beta (RETNLb) ELISA Kit
Product Code:
HUDL02527
Size:
96 Assays
Target:
RETNLb
Synonyms:
XCP2, FIZZ2, HXCP2, CCRG, RETNL2, RELMb, Foundin In Flammatory Zone 2, Colon and small intestine-specific cysteine-rich protein, Colon carcinoma-related gene protein
Detection Method:
Sandwich
Range:
62.5-4,000pg/mL
Shelf Life:
12 months
Note:
For research use only
Recovery:
Matrices listed below were spiked with certain level of recombinant the index and the recovery rates were calculated by comparing the measured value to the expected amount of the index in samples.
Matrix
Recovery range (%)
Average(%)
Serum (n=5)
80-102
91
EDTA plasma (n=5)
81-100
90
Heparin plasma (n=5)
80-89
84
Linearity:
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of the index and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample
1:2
1:4
1:8
1:16
Serum (n=5)
82-96%
83-98%
81-99%
93-101%
EDTA plasma (n=5)
88-101%
86-95%
90-102%
80-93%
Heparin plasma (n=5)
80-91%
82-90%
95-104%
79-95%
Intra-assay Precision:
Intra-Assay: CV <10%. 3 samples with low, middle and high level the index were tested 20 times on one plate, respectively.
Inter-assay Precision:
Inter-Assay: CV <12%. 3 samples with low, middle and high level the index were tested on 3 different plates, 8 replicates in each plate.
Stability:
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage conditions. Note: To minimize unnecessary influences on the performance, operation procedures and lab conditions, especially room temperature, air humidity and incubator temperatures should be strictly regulated. It is also strongly suggested that the whole assay is performed by the same experimenter from the beginning to the end.
Step
Protocol
1.
Prepare all reagents, samples and standards
2.
Add 100µL standard or sample to each well. Incubate 2 hours at 37°C
3.
Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C
4.
Aspirate and wash 3 times
5.
Add 100µL prepared Detection Reagent B. Incubate 1 hour at 37°C
6.
Aspirate and wash 5 times
7.
Add 90µL Substrate Solution. Incubate 15-25 minutes at 37°C
8.
Add 50µL Stop Solution. Read at 450nm immediately.
